Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

O&G SAQsReproductive endocrinology & infertility — fertility-treatment complications

O&G SAQs · Reproductive endocrinology & infertility — fertility-treatment complications

Severe OHSS after IVF — structured SAQ (15 marks)

FRANZCOG-format structured SAQ on severe OHSS after IVF: the Golan-REI severity grading, the resuscitation bundle (crystalloid then colloid, thromboprophylaxis, paracentesis, ICU triggers), the prophylaxis ladder (GnRH antagonist, agonist trigger, freeze-all, cabergoline 0.5 mg daily) with the trial evidence, and the prognosis for long-term ovarian function. Per-sub-part marking rubric included.

15 marks20 min4 min readVerification in progress

Target exams

FRANZCOGMRCOGABOG
On this page
Study tools

Target exams

FRANZCOGMRCOGABOG
Prompt
You are the on-call gynaecology registrar at a tertiary centre. A 31-year-old woman with PCOS and AMH 48 pmol/L underwent IVF with an antagonist cycle. On trigger day there were 28 follicles over 10 mm and oestradiol 4800 pg/mL; she received hCG 10 000 IU trigger. Six days after oocyte retrieval she presents with abdominal distension, vomiting, and oliguria for eight hours. Her weight has increased by 4 kg in 36 hours. Observations: HR 122 bpm, BP 92/56 mmHg, RR 26, SpO2 94% on room air, urine output 15 mL per hour. Examination: tense ascites, palpable bilateral ovarian masses to the umbilicus, no focal tenderness, calves soft. Bedside haematocrit is 0.51. (a) Grade the severity of her OHSS using the Golan classification with REI modification, with the criteria you used. (3 marks) (b) Outline the immediate resuscitation and supportive management bundle in the first hour. (5 marks) (c) State the prophylaxis you would have used in the cycle before trigger, naming drug, dose, route, and the trial evidence behind the most effective single intervention. (4 marks) (d) The patient asks whether her future fertility will be affected by this episode. Counsel her with the prognosis. (3 marks)

How this SAQ is marked

Twelve SAQs, 180 marks, two 2-hour papers — roughly 15 marks and 20 minutes each. Marks come from specifics: the named severity grade, the named agents and doses, the trial names behind the prophylaxis, and the prognostic reassurance that is the point of the consultation. Write short labelled points. Answer the sub-part you were asked. [1][2]

Reveal model answer and mark schemeShowHide

(a) Grade the severity of her OHSS — Golan with REI modification (3 marks)

One mark for the grade, one for the criteria, one for the classification system. [1]

  • Severe OHSS — Golan classification with the reproductive endocrinology modification. [1]
  • Criteria met — clinical (tense) ascites, oliguria under 500 mL per 24 hours (15 mL per hour for 8 hours is well under), haematocrit over 0.45 (her 0.51 qualifies), weight gain over 4.5 kg, palpable ovaries to the umbilicus. The hypotension and tachycardia are early signs of impending critical disease. [1][2]
  • Critical OHSS is defined by life-threatening complications — anuria, ARDS, thromboembolism, haematocrit over 0.55, or severe leucocytosis. She does not yet meet these criteria, but the trajectory is worrying.[2]

(b) Immediate resuscitation and supportive management bundle in the first hour (5 marks)

One mark per element with the named intervention. [1][2]

  • Admit to a monitored bed with senior cover; discuss with ICU given the deteriorating trend.
  • Two large-bore IV cannulae; send FBC, U&E, LFTs, coagulation, beta-hCG, group and save.
  • Strict fluid balance with a urinary catheter; hourly urine output is the dynamic marker.
  • Initial crystalloid — Hartmann's or normal saline 1 L over 1 hour, then maintenance.
  • Switch to colloid if haemodynamics remain unstable — 4 to 6 per cent albumin or 6 per cent hydroxyethyl starch.
  • Thromboprophylaxis with LMWH — mandatory in severe OHSS.
  • Paracentesis if the tense ascites is producing respiratory compromise or oliguria unresponsive to fluids — the most effective single intervention in established severe disease.
  • Avoid NSAIDs for analgesia (renal risk) and avoid diuretics first (intravascular depletion).
  • Analgesia with paracetamol; antiemetics.
  • Send beta-hCG — late OHSS in pregnancy will change prognosis.

(c) Prophylaxis you would have used — the cycle before trigger (4 marks)

Two marks for the most effective intervention with trial evidence, two for the alternative. [1][3][6]

  • The most effective single intervention is the combination of a GnRH antagonist protocol plus a GnRH agonist trigger (leuprolide 0.5 to 1 mg subcutaneously or triptorelin 0.2 mg subcutaneously) plus freeze-all with deferred frozen embryo transfer. Humaidan 2013 (Fertil Steril) showed severe OHSS near zero with this combination.[4][6]
  • If fresh transfer is required (cultural, religious, financial reasons), use hCG trigger (reduced dose 5000 IU) plus prophylactic cabergoline 0.5 mg orally daily for 5 to 8 days from the day of trigger — dopamine agonist reduces VEGFR-2 phosphorylation and halves moderate-to-severe OHSS. The Carizza 2008 prospective RCT (Fertil Steril) and the Tang 2012 Cochrane review support this.[3][5]
  • Additional measures — identify the at-risk patient pre-cycle (PCOS, AMH over 35 pmol/L, antral follicle count over 24); consider in-vitro maturation as a no-stimulation alternative.[6]

(d) Prognosis and counselling for future fertility (3 marks)

One mark for the prognostic statement, one for the disease course, one for the future-cycle plan. [1][2]

  • Long-term ovarian function is preserved — OHSS does not accelerate follicular depletion; her future natural or stimulated fertility is unaffected.
  • The disease itself will resolve over 7 to 14 days if she is not pregnant (early OHSS) or 2 to 3 weeks if she is pregnant (late OHSS). She is at risk of progression to critical OHSS if not optimally managed.
  • For her next cycle — pre-cycle counselling, GnRH antagonist protocol with agonist trigger and freeze-all, prophylactic cabergoline, and an explicit note in the record about her prior severe OHSS. Recurrence risk is high in subsequent cycles without prophylaxis modification.
  • Critical reassurance — most women who conceive after an OHSS episode have a healthy pregnancy and a healthy baby; OHSS is a treatable condition.
Obstetrics & Gynaecology Pro

Continue reading

You have read the opening of this SAQ. The complete unit — every section and its primary-source references — is part of the Obstetrics & Gynaecology fellowship library.

Sign in to continueSee pricing
References6ShowHide
  1. [1]Kwik M, Karia S, Boothroyd C RANZCOG CREI Consensus Statement on treatment of Ovarian Hyperstimulation Syndrome. Aust N Z J Obstet Gynaecol, 2015.PMID 26279582
  2. [2]Practice Committee of the American Society for Reproductive Medicine. Prevention of moderate and severe ovarian hyperstimulation syndrome: a guideline. Fertil Steril, 2024.PMID 38099867
  3. [3]Carizza C, Abdelmassih V, Abdelmassih S, Ravizzini P, et al. Cabergoline reduces the early onset of ovarian hyperstimulation syndrome: a prospective randomized study. Reprod Biomed Online, 2008.PMID 19079957
  4. [4]Humaidan P, Polyzos NP, Alsbjerg B, et al. GnRHa trigger and individualized luteal phase hCG support according to ovarian response to stimulation: two prospective randomized controlled multi-centre studies in IVF patients. Hum Reprod, 2013.PMID 23753114
  5. [5]Tang H, Mourad SM, Wang A, Zhai SD, et al. Dopamine agonists for preventing ovarian hyperstimulation syndrome. Cochrane Database Syst Rev, 2021.PMID 33851429
  6. [6]Leathersich S, Roche C, Hart R Minimising OHSS in women with PCOS. Front Endocrinol (Lausanne), 2025.PMID 40182629
Obstetrics & Gynaecology Pro

$29/ monthor $279 / year

The complete Obstetrics & Gynaecology library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousSecondary postpartum haemorrhage — structured SAQ (15 marks)Postpartum care — haemorrhageNextSexual dysfunction and dyspareunia — structured SAQ (15 marks)Sexual and reproductive health